Stockreport

Novan to Present Data from SB414 Phase 1b Atopic Dermatitis Clinical Trial at 3rd Inflammatory Skin Disease Summit

Novan, Inc.  (NOVN) 
Last novan, inc. earnings: 11/12 04:23 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.novan.com
PDF Clinical efficacy, as measured by EASI (Eczema Area and Severity Index) changes, was numerically greater for SB414 treated groups compared to vehicle  Strong anti-prurit [Read more]